
doi: 10.1111/liv.14798
pmid: 33503328
AbstractBackground and AimsDifferences in combined hepatocellular‐cholangiocarcinomas (cHCC‐CCAs) arising in high‐risk patients with or without liver cirrhosis have not been elucidated. This study aimed to compare the clinicopathologic and imaging characteristics of cHCC‐CCAs in patients with or without cirrhosis and to determine the prognostic factors for recurrence‐free survival (RFS) after curative resections of single cHCC‐CCAs.MethodsThis retrospective study included 113 patients with surgically resected single cHCC‐CCAs who underwent preoperative magnetic resonance imaging from January 2008 to December 2019 at two tertiary referral centres. Clinical, pathologic and imaging features of tumours were compared in high‐risk patients with or without cirrhosis. Imaging features were assessed using the Liver Imaging Reporting and Data System (LI‐RADS) version 2018. RFS and associated factors were evaluated using Cox proportional hazards regression analysis, Kaplan‐Meier analysis and log‐rank test.ResultscHCC‐CCAs arising from cirrhotic livers had a smaller mean tumour size (2.9 cm vs. 4.5 cm; P < .001) and were more frequently categorized as LR‐5 or 4 (41.2% vs. 20.0%; P = .024) than those arising from non‐cirrhotic livers. In multivariable analysis, a tumour size of > 3 cm (hazard ratio [HR], 2.081; 95% confidence interval [CI], 1.180‐3.668; P = .011) and the LR‐M category (HR, 2.302; 95% CI, 1.198‐4.424; P = .012) were independent predictors associated with worse RFS.ConclusionsThe tumour size and distribution of LI‐RADS categories of cHCC‐CCAs differed in high‐risk patients with or without cirrhosis. And LR‐M category was a worse prognosis predictor after curative resections than LR‐5 or 4 category.
Liver Cirrhosis, Carcinoma, Hepatocellular, 610, Contrast Media, Cholangiocarcinoma, Liver Neoplasms* / diagnostic imaging, Humans, Retrospective Studies, Intrahepatic, Cholangiocarcinoma* / diagnostic imaging, combined hepatocellular-cholangiocarcinoma, cirrhosis, Carcinoma, Liver Neoplasms, Bile Duct Neoplasms* / surgery, Magnetic Resonance Imaging, Bile Ducts, Intrahepatic, Bile Duct Neoplasms, Bile Duct Neoplasms* / diagnostic imaging, Hepatocellular* / diagnostic imaging, Bile Ducts, prognosis, Liver Cirrhosis / diagnostic imaging
Liver Cirrhosis, Carcinoma, Hepatocellular, 610, Contrast Media, Cholangiocarcinoma, Liver Neoplasms* / diagnostic imaging, Humans, Retrospective Studies, Intrahepatic, Cholangiocarcinoma* / diagnostic imaging, combined hepatocellular-cholangiocarcinoma, cirrhosis, Carcinoma, Liver Neoplasms, Bile Duct Neoplasms* / surgery, Magnetic Resonance Imaging, Bile Ducts, Intrahepatic, Bile Duct Neoplasms, Bile Duct Neoplasms* / diagnostic imaging, Hepatocellular* / diagnostic imaging, Bile Ducts, prognosis, Liver Cirrhosis / diagnostic imaging
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 10 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
